Reaction Details |
| Report a problem with these data |
Target | Neuropeptide Y receptor type 5 |
---|
Ligand | BDBM50116603 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_143678 (CHEMBL755166) |
---|
IC50 | 15±n/a nM |
---|
Citation | Block, MH; Boyer, S; Brailsford, W; Brittain, DR; Carroll, D; Chapman, S; Clarke, DS; Donald, CS; Foote, KM; Godfrey, L; Ladner, A; Marsham, PR; Masters, DJ; Mee, CD; O'Donovan, MR; Pease, JE; Pickup, AG; Rayner, JW; Roberts, A; Schofield, P; Suleman, A; Turnbull, AV Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity. J Med Chem45:3509-23 (2002) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuropeptide Y receptor type 5 |
---|
Name: | Neuropeptide Y receptor type 5 |
Synonyms: | NPY-Y5 | NPY-Y5 receptor | NPY5-R | NPY5R | NPY5R_HUMAN | NPYR5 | NPYY5 | Neuropeptide Y receptor type 5 | Neuropeptide Y receptor type 5 ( NPY Y5) | Y5 receptor |
Type: | Enzyme |
Mol. Mass.: | 50746.64 |
Organism: | Homo sapiens (Human) |
Description: | Q15761 |
Residue: | 445 |
Sequence: | MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM
|
|
|
BDBM50116603 |
---|
n/a |
---|
Name | BDBM50116603 |
Synonyms: | CHEMBL443809 | Morpholine-4-carboxylic acid (9-methanesulfonyl-9H-carbazol-3-yl)-amide |
Type | Small organic molecule |
Emp. Form. | C18H19N3O4S |
Mol. Mass. | 373.426 |
SMILES | CS(=O)(=O)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc12 |
Structure |
|